In this panel discussion hosted by Harvard SEAS, experts will discuss the essential role of scientists and engineers in the design and development of equitable vaccine clinical trials.

Register Here

The panel will aim to address how specific populations have been historically marginalized in the drug development process, and how critical planning and implementation can help ensure better outcomes for all.

Meet the panel:

Gilda Barabino, President at Franklin W. Olin College of Engineering
Melanie Ivarsson, SVP, Chief Development Officer, Moderna
Jayne Morgan, MD, Cardiologist and Clinical Director of the Covid Task Force at the Piedmont Healthcare Corporation

Moderated by:

Francis J. Doyle III, Dean of the Harvard John A. Paulson School of Engineering and Applied Sciences; John A. and Elizabeth S. Armstrong Professor of Engineering and Applied Sciences

Part of the Harvard SEAS Industry Insights series.